Bristol-Myers in $300m settlement
US drugs company Bristol-Myers Squibb has agreed to pay $300m (£165m) into a shareholders’ fund, as prosecutors charged two former executives.
The firm and executives were accused of a practice called “channel stuffing” – offering incentives to get wholesalers to buy more of the company’s products.
The scheme boosted earnings at the firm, which has now agreed a “deferred prosecution” with Newark lawmakers
